Nanotechology-based strategies to enhance the efficacy of photodynamic therapy for cancers

Current Drug Metabolism

Volumn 10, Issue 8, 2009, Pages 851-860

  Li, Wen Tyng ^a  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Anticancer treatment; Nanoparticle; Photodynamic therapy; Photosensitizer; Targeted delivery

Indexed keywords

2 (1 HEXYLOXYETHYL) 2 DEVINYL PYROPHEOPHORBIDE ALPHA; ALGINIC ACID; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID METHYL ESTER; CHOLINIUM PURPURIN 18; DEXTRAN; FULLERENE; GELATIN; HEMATOPORPHYRIN; HEMATOPORPHYRIN DERIVATIVE; IONIC LIQUID; LUTETIUM TEXAPHYRIN; NANOPARTICLE; PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOCAN; PHOTOCHLOR; PHOTOFRIN; PHOTOSAN; PHOTOSENS; PHOTOSENSITIZING AGENT; PHTHALOCYANINE; PHTHALOCYANINE ALUMINUM; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; PROTOPORPHYRIN; STAKEL; TALAPORFIN; TEMOPORFIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERTEPORFIN; WST 11;

ANIMAL MODEL; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMBRYO; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MOUSE; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; PEER REVIEW; PHOTODYNAMIC THERAPY; RAT; RETINA MACULA DEGENERATION; THERAPY EFFECT;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, INVESTIGATIONAL; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 74249108442     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009790274559     Document Type: Article

References (85)

1. Dolmans, D.E.J.G.J.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancers, 2003, 3(5), 380-387.
2. Triesscheijn, M.; Baas, P.; Schellens, J.H.M.; Stewart, F.A. Photodynamic therapy in oncology. Oncologist, 2006, 11(9), 1034-1044.
3. Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: part one- photosensitizers, photochemistry and cellular localization. Photodiag. Photodyn. Ther., 2004, 1(4), 279-293.
4. Moor, A.C.E. Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol., 2000, 57(1):1-13.
5. Wyld, L.; Reed M.W.R.; Brown, N.J. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br. J. Cancer, 2001, 84(10), 1384-1386.
6. Brown, S.B.; Brown, E.A.; Walker, I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol., 2004, 5(8), 497-508.
7. Bechet, D.; Couleaud, P.; Frochot, C.; Viriot, M.-L.; Guillemin, F.; Barberi-Heyob, M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotech., 2008, 26(11), 612-621.
8. Chatterjee, D.K.; Fong, L.S.; Zhang, Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliv. Rev., 2008, 60(15), 1627-1637.
9. Allison, R.R.; Downie, G.H.; Cuenca, R.; Hu, X.-H.; Childs, C.J.H.; Sibata, C.H. Photosensitizers in clinical PDT. Photodiag. Photodyn. Ther., 2004, 1(1), 27-42.
10. Pandey, R.K.; Goswami, L.N; Chen, Y.; Gryshuk, A; Missert, J.R.; Oseroff, A.; Dougherty, T.J. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy. Lasers Surg. Med., 2006, 38(5), 445-467.
11. Hajri, A.; Wack, S.; Meyer, C.; Smith, M.K.; Leberquier, C.; Kedinger, M.; Aprahamian, M. In vitro and in vivo efficacy of photofrin®
12. and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem. Photobiol., 2002, 75(2), 140-148.
13. Lim, D.-S.; Ko, S.-H; Lee W.-Y. Silkworm-pheophorbide a mediated photodynamic therapy against B16F10 pigmented melanoma. J. Photochem. Photobiol. B, 2004, 74(1), 1-6.
14. Xu, C.S.; Leung A.W.N. Photodynamic effects of pyropheophorbide-a methyl ester in nasopharyngeal carcinoma cells. Med. Sci. Monit., 2006, 12(8), BR257-262.
15. Tang, P.M.; Chan, J.Y.; Au, S.W.; Kong, S.K.; Tsui, S.K.; Waye, M.M.; Mak, T.C.; Fong, W.P.; Fung, K.P. Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol. Ther., 2006, 5(9), 1111-1116.
16. Xu, D.-Y. Research and development of photodynamic therapy photosensitizers in China, Photodiag. Photodyn. Ther., 2007, 4(1), 13-25.
17. Li, W.-T.; Tsao, H.-W.; Chen, Y.-Y.; Cheng, S.-W.; Hsu, Y.-C. A study on the photodynamic properties of chlorophyll derivatives using human hepatocellular carcinoma cells. Photochem. Photobiol. Sci., 2007, 6(12), 1341-1348.
18. Jori, G. Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J. Photochem. Photobiol. B, 1996, 36(2), 97-93.
19. Mroz, P.; Tegos, G.P.; Gali, H.; Wharton, T.; Sarna, T.; Hamblin, M.R. Photodynamic therapy with fullerenes. Photochem. Photobiol. Sci., 2007, 6(11), 1139-1149.
20. Da Ros, T.; Prato, M. Medicinal chemistry with fullerenes and fullerene derivatives. Chem. Comm., 1999, 21(8), 663-669.
21. Burlaka, A.P.; Sidorik, Y.P.; Prylutska, S.V.; Matyshevska, O.P.; Golub, O.A.; Prylutskyy, Y.I.; Scharff, P. Catalytic system of the reactive oxygen species on the C60 fullerene basis. Exp. Oncol., 2004, 26(4), 326-327.
22. Mroz, P.; Pawlak, A.; Satti, M.; Lee, H.; Wharton, T.; Gali, H.; Sarna, T.; Hamblin, M.R. Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med., 2007, 43(5), 711-719.
23. Doi, Y.; Ikeda, A.; Akiyama, M.; Nagano, M.; Shigematsu, T.; Ogawa, T.; Takeya, T.; Nagasaki, T. Intracellular uptake and photodynamic activity of water-soluble [60]- and [70]fullerenes incorporated in liposomes. Chemistry, 2008, 14(29), 8892-8897.
24. Hubbard, S.C.; Jones, P.B. Ionic liquid soluble photosensitizers. Tetrahedron, 2005, 61(31), 7425-7430.
25. Demberelnyamba, D.; Ariunaa, M.; Shim, Y.K. Newly synthesized water soluble cholinium-purpurin photosensitizers and their stabilized gold nanoparticles as promising anticancer agents. Int. J. Mol. Sci., 2008, 9(5), 864-871.
26. Baba, K.; Pudavar, H.E; Roy, I.; Ohulchanskyy, T.Y.; Chen, Y; Pandey, R.K.; Prasad, P.N. New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug. Mol. Pharma., 2008, 4(2), 289-297.
27. Konan, Y.N.; Gurny, R.; Allémann, E. State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B, 2002, 66(2), 89-106.
28. Konan, Y.N.; Berton, M.; Gurny, R.; Allémann, E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur. J. Pharm. Sci., 2003, 18(3-4), 241-249.
29. Ricci-Júnior, E.; Marchetti, J.M. Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc(II) phthalocyanine for photodynamic therapy use. J. Microencapsul., 2006, 23(5), 523-538.
30. Ricci-Júnior, E.; Marchetti, J.M. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm., 2006, 310(1-2), 187-195.
31. Gomes, A.J.; Lunardi, L.O.; Marchetti, J.M.; Lunardi, C.N.; Tedesco, A.C. Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment. Drug Deliv., 2005, 12(3), 159-164.
32. Gomes, A.J; Lunardi, C.N; Tedesco, A.C. Characterization of biodegradable poly(D,L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. Photomed. Laser Surg., 2007, 25(5), 428-435.
33. McCarthy, J.R.; Perez, J.M.; Brückner, C.; Weissleder, R. Polymeric nanoparticle preparation that eradicates tumors. Nano Lett., 2005, 5(12), 2552-2556.
34. Zeisser-Labouèbe, M.; Lange, N.; Gurny, R.; Delie, F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int. J. Pharm., 2006, 326(1-2), 174-181.
35. Zeisser-Labouèbe, M.; Delie, F.; Gurny, R.; Lange, N. Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases. Eur. J. Pharm. Biopharm., 2009, 71(2), 207-213.
36. Vargas, A.; Pegaz, B.; Debefve, E.; Konan-Kouakou, Y.; Lange, N.; Ballini, J.P.; van den Bergh, H.; Gurny, R.; Delie, F. Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int. J. Pharm., 2004, 286(1-2), 131-145.
37. Vargas, A.; Lange, N.; Arvinte, T.; Cerny, R.; Gurny, R.; Delie, F. Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity. J. Drug Target., 2009, 17(8), 599-609.
38. Pegaz, B.; Debefve, E.; Borle, F.; Ballini, J.P.; van den Bergh, H.; Kouakou-Konan, Y.N. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study. J. Photochem. Photobiol. B, 2005, 80(1), 19-27.
39. Gillies E.R.; Fréchet, J.M.J. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today, 2005, 10(1), 35-43.
40. Battah, S.H.; Chee, C.E.; Nakanishi, H.; Gerscher, S.; MacRobert, A.J.; Edwards C. Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy. Bioconjug. Chem., 2001, 12(6), 980-988.
41. Battah, S.; Balaratnam, S.; Casas, A.; O'Neill, S.; Edwards, C.; Batlle, A.; Dobbin, P.; MacRobert, A.J. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol. Cancer Ther., 2007, 6(3), 876-885.
42. Casas, A.; Battah, S.; Di Venosa, G.; Dobbin, P.; Rodriguez, L.; Fukuda, H.; Batlle, A.; MacRobert, A.J. Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy. J. Control. Release, 2009, 135(2), 136-143.
43. Kojima, C.; Toi, Y.; Harada, A.; Kono, K. Preparation of poly(ethylene glycol)-attached dendrimers encapsulating photosensitizers for application to photodynamic therapy. Bioconjug. Chem., 2007, 18(3), 663-670.
44. Nishiyama, N.; Nakagishi, Y.; Morimoto, Y.; Lai, P.S.; Miyazaki, K.; Urano, K.; Horie, S.; Kumagai, M.; Fukushima, S.; Cheng, Y.; Jang, W.D.; Kikuchi, M.; Kataoka, K. Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. J. Control. Release, 2009, 133(3), 245-251.
45. Sortino, S.; Mazzaglia, A.; Monsù Scolaro, L.; Marino Merlo, F.; Valveri, V.; Sciortino, M.T. Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as carrier-sensitizer system in photodynamic cancer therapy. Biomaterials, 2006, 27(23), 4256-4265.
46. Augst, A.D.; Kong, H.J.; Mooney D.J. Alginate hydrogels as biomaterials. Macromol. Biosci., 2006, 6(8), 623-633.
47. Khdair, A.; Gerard, B.; Handa, H.; Mao, G.; Shekar, M.P.V.; Panyam, J. Surfactant-polymer nanoparticles enhances the effectiveness of anticancer photodynamic therapy. Mol. Pharm., 2008, 5(5), 795-807.
48. Khdair, A.; Handa, H.; Mao, G.; Panyam, J. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro. Eur. J. Pharm. Biopharm., 2009, 71(2), 214-222.
49. Lee, S.J.; Park, K.; Oh, Y.K.; Kwon, S.H.; Her, S.; Kim, I.S.; Choi, K.; Lee, S.J.; Kim, H.; Lee, S.G.; Kim, K.; Kwon, I.C. Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials, 2009, 30(15), 2929-2939.
50. Yan, F.; Kopelman, R. The embedding of meta-tetra(hydroxyphenyl)- chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties. Photochem. Photobiol., 2003, 78(6), 587-591.
51. Podbielska, H.; Ulatowska-Jarza, A.; Müller, G.; Holowacz, I.; Bauer, J.; Bindig, U. Silica sol-gel matrix doped with Photolon molecules for sensing and medical therapy purposes. Biomol. Eng., 2007, 24(5), 425-433.
52. Rossi, L.M.; Silva, P.R.; Vono, L.L.; Fernandes, A.U.; Tada, D.B.; Baptista, M.S. Protoporphyrin IX nanoparticle carrier: preparation, optical properties, and singlet oxygen generation. Langmuir, 2008, 24(21), 12534-12538.
53. Qian, J.; Gharibi, A.; He, S. Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy. J. Biomed. Opt., 2009, 14(1), 014012.
54. Roy, I.; Ohulchanskyy, T.Y.; Pudavar, H.E.; Bergey, E.J.; Oseroff, A.R.; Morgan, J.; Dougherty, T.J.; Prasad, P.N. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc., 2003, 125(26), 7860-7865.
55. Kim, S.; Ohulchanskyy, T.Y.; Pudavar, H.E.; Pandey, R.K.; Prasad, P.N. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. J. Am. Chem. Soc., 2007, 129(9), 2669-2675.
56. Ohulchanskyy, T.Y.; Roy, I.; Goswami, L.N.; Chen, Y.; Bergey, E.J.; Pandey, R.K.; Oseroff, A.R.; Prasad PN. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett., 2007, 7(9), 2835-2842.
57. Tang, W.; Xu, H.; Kopelman, R.; Philbert, M.A. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem. Photobiol., 2005, 81(2), 242-249.
58. Tada, D.B.; Vono, L.L.; Duarte, E.L.; Itri, R.; Kiyohara, P.K.; Baptista, M.S.; Rossi, L.M. Methylene blue-containing silica-coated magnetic particles: a potential magnetic carrier for photodynamic therapy. Langmuir, 2007, 23(15), 8194-9199.
59. He, X.; Wu, X.; Wang, K.; Shi, B.; Hai, L. Methylene blue-encapsulated phosphonate-terminated silica nanoparticles for simultaneous in vivo imaging and photodynamic therapy. Biomaterials, 2009, 30(29), 5601-5609.
60. Wang, S.; Gao, R.; Zhou, F,; Selke M. Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy. J. Mater. Chem., 2004, 14(4), 487-493.
61. Samia, A.C.; Chen, X.; Burda, C. Semiconductor quantum dots for photodynamic therapy. J. Am. Chem. Soc., 2003, 125(51), 15736-15737.
62. Dayal, S.; Lou, Y.; Samia, A.C.; Berlin, J.C.; Kenney, M.E.; Burda, C. Observation of non-Förster-type energy-transfer behavior in quantum dot-phthalocyanine conjugates. J. Am. Chem. Soc., 2006, 128(43), 13974-13975.
63. Ma, J.; Chen, J.Y.; Idowu, M.; Nyokong, T. Generation of singlet oxygen via the composites of water-soluble thiol-capped CdTe quantum dots-sulfonated aluminum phthalocyanines. J. Phys. Chem. B, 2008, 112(15), 4465-4469.
64. Connor, E.E.; Mwamuka, J.; Gole, A.; Murphy, C.J.; Wyatt, M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 2005, 1(3), 325-327.
65. Ghosha, P.; Hana, G.; Dea, M.; Kima C.K.; Rotello, V.M. Gold nanoparticles in delivery applications. Adv. Drug. Deliv. Rev., 2008, 60(11), 1307-1315.
66. Hone, D.C.; Walker, P.I.; Evans-Gowing, R.; FitzGerald, S.; Beeby, A.; Chambrier, I.; Cook, M.J.; Russell D.A. Generation of cytotoxic singlet oxygen via phthalocyanine-stabilized gold nanoparticles: a potential delivery vehicle for photodynamic therapy. Langmuir, 2002, 18(8), 2985-2987.
67. Wieder, M.E.; Hone, D.C.; Cook, M.J.; Handsley, M.M.; Gavrilovic, J.; Russell, D.A. Intracellular photodynamic therapy with photosensitizer- nanoparticle conjugates: cancer therapy using a 'Trojan horse'. Photochem. Photobiol. Sci., 2006, 5(8), 727-734.
68. Cheng, Y.; Samia, A.C.; Meyers, J.D.; Panagopoulos, I.; Fei, B.; Burda, C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J. Am. Chem. Soc., 2008, 130(32), 10634-10647.
69. Oo, M.K.; Yang, X.; Du, H.; Wang, H. 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomed., 2008, 3(6), 777-786.
70. Juzenas, P.; Chen, W.; Sun, Y.P.; Coelho, M.A.; Generalov, R.; Generalova, N.; Christensen, I.L. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev., 2008, 60(15), 1600-1614.
71. Chen, B.; Pogue, B.W.; Hoopes, P.J.; Hasan, T. Vascular and cellular targeting for photodynamic therapy. Crit. Rev. Eukaryot. Gene Expr., 2006, 16(4), 279-305.
72. Solban N.; Rizvi I.; Hasan T. Targeted photodynamic therapy. Lasers Surg. Med., 2006, 38(5), 522-531.
73. Vrouenraets, M.B.; Visser, G.W.; Loup, C.; Meunier, B.; Stigter, M.; Oppelaar, H.; Stewart, F.A.; Snow, G.B.; van Dongen, G.A. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy. Int. J. Cancer, 2000, 88(1), 108-114.
74. Soukos, N.S.; Hamblin, M.R.; Keel, S.; Fabian, R.L.; Deutsch, T.F.; Hasan, T. Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res., 2001, 61(11), 4490-4496.
75. Staneloudi, C.; Smith, K.A.; Hudson, R., Malatesti, N.; Savoie, H.; Boyle, R.W.; Greenman, J. Development and characterization of novel photosensitizer: scFv conjugates for use in photodynamic therapy of cancer. Immunology, 2007, 120(4), 512-517.
76. Bhatti, M.; Yahioglu, G.; Milgrom, L.R.; Garcia-Maya, M.; Chester, K.A.; Deonarain, M.P. Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments. Int. J. Cancer, 2008, 122(5), 1155-1163.
77. Gijsens, A.; Derycke, A.; Missiaen, L.; De Vos, D.; Huwyler, J.; Eberle, A.; de Witte, P. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes. Int. J. Cancer, 2002, 101(1), 78-85.
78. Laptev, R.; Nisnevitch, M.; Siboni, G.; Malik, Z.; Firer, M.A. Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells. Br. J. Cancer, 2006, 95(2), 189-196.
79. Sudimack, J.; Lee, R.J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev., 2000, 41(2), 147-162.
80. Stefflova, K.; Li, H.; Chen, J.; Zheng, G. Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. Bioconjug. Chem., 2007, 18(2), 379-388.
81. Gravier, J.; Schneider, R.; Frochot, C.; Bastogne, T.; Schmitt, F.; Didelon, J.; Guillemin, F.; Barberi-Heyob, M. Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies. J. Med. Chem., 2008, 51(13), 3867-3877.
82. Swamy, N.; James, D.A.; Mohr, S.C.; Hanson, R.N.; Ray, R. An estradiol-porphyrin conjugate selectively localizes into estrogen receptor-positive breast cancer cells. Bioorg. Med. Chem., 2002, 10(10), 3237-3243.
83. Swamy, N.; Purohit, A.; Fernandez-Gacio, A.; Jones, G.B.; Ray, R. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate. J. Cell. Biochem., 2006, 99(3), 966-977.
84. Rosenkranz, A.A.; Lunin, V.G.; Gulak, P.V.; Sergienko, O.V.; Shumiantseva, M.A.; Voronina, O.L.; Gilyazova, D.G.; John, A.P.; Kofner, A.A.; Mironov, A.F.; Jans, D.A.; Sobolev, A.S. Recombinant modular transporters for cell-specific nuclear delivery of locally acting drugs enhance photosensitizer activity. FASEB J., 2003, 17(9), 1121-1123.
85. Mallikaratchy, P.; Tang, Z.; Tan, W. Cell specific aptamer- photosensitizer conjugates as a molecular tool in photodynamic therapy. Chem. Med. Comm., 2008, 3(3), 425-428.